NAMD Prepares Memo on AAC Prescription Drug Reimbursement Methodology

The National Association of Medicaid Directors released a public memo which discusses average acquisition cost (AAC) methodologies for Medicaid prescription drug reimbursement. The memo also provides an update on CMS’s progress finalizing average market price-based Federal Upper Limits (AMP-based FULs) for prescription drugs.

Read the full memo here.

Comments are closed.